Orrin Hatch: “FDA's proposal to regulate LDTs is a significant change that would impose considerable new burdens on regulated parties.”

I stand by everything I said during my questioning of Mr. Saul, including concerns about budget summary data.

I want to thank my dear colleague from Iowa. He is one of the greatest Senators I have served with. He is just a wonderful friend and a wonderful Senator. He has worked his tail off the whole time he has been here. I am grateful for his…

Having a confirmed Commissioner, and sustained leadership, will benefit the Social Security Administration.

I say, 'damn right.'